🏛️ Verified NIH Record • Updated 2026-03-17
Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD) (NCT07059962)
🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Bodyport Inc.
🩺 Plain-English Summary (8th-Grade Level)
To explore the use of the Bodyport Cardiac Scale in predicting worsening of events due to fluid overload in patients with kidney disease on peritoneal dialysis.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (5 items) and avoid the listed exclusions (7 items).
Location: Desert Cities Dialysis — Victorville, California
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Undergoing or plan to undergo hemodialysis in the next 12 months
- Have a life expectancy of less than 12 months
- Are pregnant or plan to become pregnant during the next 12 months
- Weigh greater than 375 lbs
- Planned kidney transplant within the next 12 months
- Have an implanted neurostimulator system
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (4 Sites)
- Desert Cities Dialysis — Victorville, California
- Southeastern Clinical Research Institute — Augusta, Georgia
- Northwestern University — Chicago, Illinois
- Seven Oaks General Hospital — Winnipeg, Manitoba
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.